CA Patent

CA2075627A1 — Angiotensin ii antagonists incorporating a substituted benzyl element

Assigned to Merck and Co Inc · Expires 1991-08-14 · 35y expired

What this patent protects

Substitued heterocycles attached through a methylene bridge to novel substituted phenyl derivatives of Formula (1) useful as angiotensin 11 antagonists.

USPTO Abstract

Substitued heterocycles attached through a methylene bridge to novel substituted phenyl derivatives of Formula (1) useful as angiotensin 11 antagonists.

Drugs covered by this patent

Patent Metadata

Patent number
CA2075627A1
Jurisdiction
CA
Classification
—
Expires
1991-08-14
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.